Fortress Biotech (FBIO) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $8.8 million.
- Fortress Biotech's Income towards Parent Company rose 13302.9% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 3667.35%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
- Per Fortress Biotech's latest filing, its Income towards Parent Company stood at $8.8 million for Q3 2025, which was up 13302.9% from -$35.9 million recorded in Q2 2025.
- Fortress Biotech's Income towards Parent Company's 5-year high stood at $8.8 million during Q3 2025, with a 5-year trough of -$62.4 million in Q4 2021.
- In the last 5 years, Fortress Biotech's Income towards Parent Company had a median value of -$35.9 million in 2025 and averaged -$37.1 million.
- As far as peak fluctuations go, Fortress Biotech's Income towards Parent Company plummeted by 15968.02% in 2021, and later skyrocketed by 13302.9% in 2025.
- Quarter analysis of 5 years shows Fortress Biotech's Income towards Parent Company stood at -$62.4 million in 2021, then increased by 7.88% to -$57.4 million in 2022, then skyrocketed by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then soared by 133.54% to $8.8 million in 2025.
- Its Income towards Parent Company stands at $8.8 million for Q3 2025, versus -$35.9 million for Q2 2025 and -$21.8 million for Q1 2025.